startquestionstalksour storystories
tagspreviousget in touchlatest

Meta stock jumps as Wells Fargo raises price target

September 22, 2026 - 00:45

Meta stock jumps as Wells Fargo raises price target

Meta shares surged more than 10 percent during trading after Wells Fargo raised its price target on the stock from $640 to $796. The significant bump in the target price reflects growing confidence in the company's direction, particularly around its artificial intelligence initiatives.

The rally was not driven by the analyst note alone. Meta also received a boost from its Meta Muse AI agent app, which climbed to the top spot on Apple's App Store. That milestone highlights the momentum building around the company's AI push and suggests users are responding positively to its latest product offerings.

The combination of an upgraded price target and a top-ranking app gave investors two concrete reasons to buy into the stock. Wells Fargo's new target implies considerable upside from recent trading levels, and the App Store performance offers a tangible sign that Meta's AI investments are gaining traction with consumers.

Meta has been pouring resources into AI development as it looks to compete with other major technology firms racing to build the next generation of AI tools. The Muse app's rise to number one on Apple's platform signals that those efforts may be starting to pay off in visible ways.

Shares closed the session sharply higher, marking one of the stock's strongest single-day performances in recent months.


MORE NEWS

Charleston County Leaders to Consider $3 Million for Land Preservation

November 5, 2026 - 18:54

Charleston County Leaders to Consider $3 Million for Land Preservation

Charleston County leaders will be meeting Thursday to discuss a request for over $3 million in Greenbelt funding, which would go toward preserving and protecting land in Hollywood. This funding is...

Agenus Aims for Phase 3 Trial in Colon Cancer as Funding Depends on Enrollment

November 5, 2026 - 18:37

Agenus Aims for Phase 3 Trial in Colon Cancer as Funding Depends on Enrollment

Agenus plans to start patient enrollment in the coming months for a Phase 3 trial of its investigational immunotherapy combination BOT/BAL aimed at treating early-stage colon cancer. During a...

Burford Capital Shares Financial Performance for Third Quarter and Year-to-Date 2026

November 4, 2026 - 20:16

Burford Capital Shares Financial Performance for Third Quarter and Year-to-Date 2026

Burford Capital Limited has released its unaudited financial results for the third quarter and year-to-date ending September 30, 2026. The firm, known for its focus on finance and asset management...

GM Financial Announces Transfer of Stock Exchange Listing to Nasdaq

November 3, 2026 - 18:22

GM Financial Announces Transfer of Stock Exchange Listing to Nasdaq

FORT WORTH, Texas, November 03, 2026-- GM Financial has officially announced its decision to transfer the listing of its senior notes to the Nasdaq Global Market. This change involves $750 million...

read all news
startquestionstalksour storystories

Copyright © 2026 PayTaxo.com

Founded by: Yasmin McGee

tagseditor's choicepreviousget in touchlatest
your datacookie settingsuser agreement